The NextSeq 550Dx makes it easy to meet your needs with flexible read lengths and multiple output configurations. Access a growing pipeline of assays with shortened turnaround times, streamlined data analysis, and accuracy, all within a user-friendly interface.
Explore solutions for expecting parents, noninvasive prenatal testing (NIPT), chromosomal analysis for preimplantation genetic screening (PGS), and genetic testing for rare diseases with the NextSeq 550Dx instrument.
NGS is transforming oncology by offering a more comprehensive and deeper understanding of cancers and tumors. See how to deliver accurate, sensitive, and fast results with the NextSeq 550Dx for oncology testing.
Customize your NGS-based IVD assays for analysis on the NextSeq 550Dx instrument platform. We’re even collaborating with diagnostic technology partners to expand our menu of clinical assays to help pave the way for more accurate diagnosis, prognosis, and therapeutic options.
For In Vitro Diagnostic Use. Contact an Illumina representative for regional availably.
At Illumina, we are committed to improving human health by unlocking the power of the genome. For more than a decade, we’ve brought our unparalleled expertise as a genomics industry leader to revolutionize healthcare through next-generation sequencing (NGS)-based diagnosticsDownload the Dx Platforms Brochure
Work within a regulated sequencing workflow for developing current and future NGS IVD tests in the pipeline, while retaining the flexibility to work in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.
The instrument and sequencing reagents are all regulated by the FDA, developed under design control principles, manufactured under Current Good Manufacturing Practices (cGMPs), and verified for consistent assay performance.
Paired with the TruSeq Custom Amplicon Kit Dx library preparation kit and the NextSeq 550Dx Reagent Kit, the NextSeq 550Dx is part of an IVD development toolkit that enables clinical labs to design clinical assays with regulated components*.
The NextSeq 550Dx offers powerful and flexible clinical workflow options in an intuitive system. Take advantage of a broad offering of compliant components or design custom assays for various clinical research applications.
A library preparation and enrichment solution for in vitro diagnostic (IVD) targeted sequencing applications.
These sequencing reagent kits offer a simplified workflow and high data quality for in vitro diagnostic testing
Local Run Manager (LRM) software is an integrated solution designed to create sequencing runs, monitor run status, analyze sequencing data, and view results.
*Contact your Illumina representative for more information about IVD development partnerships.
The NextSeq 550Dx instrument is intended for targeted sequencing of DNA libraries from human genomic DNA extracted from peripheral whole blood or formalin-fixed, paraffin-embedded (FFPE) tissue, when used for in vitro diagnostic (IVD) assays performed on the instrument. The NextSeq 550Dx instrument is not intended for whole genome or de novo sequencing. The NextSeq 550Dx instrument is to be used with specific registered and listed, cleared or approved, IVD reagents and analytical software.
The NextSeq 550Dx instrument is intended for sequencing of DNA libraries when used with in vitro diagnostic (IVD) assays performed on the instrument. The NextSeq 550Dx instrument is to be used with specific registered, certified or approved in vitro diagnostic reagents and analytical software.